Data driven insights for disease and drug research

Get started Free for Academics!
Learn more
Enabling world leading pharma, biotech and academic institutions
Genmab
Janssen and Janssen Pharmaceutical Companies
Leiden Academic Centre for Drug Research
Astra Zeneca
Boehringer Ingelheim
Tufts University
Euretos
Mission

Transforming disease and drug research

We collaborate with our customers to unravel the complexities of human disease biology, reducing the risk and cost of therapy development. We generate data driven disease insights through a unique combination of AI driven, computational disease models, translational biology consultancy and direct access to the Euretos AI platform. This empowers our customers to draw their own conclusions and take a data driven approach to disease and drug research.
x
Euretos
Disease Modelling

AI driven computational disease models

Our computational disease models leverage the Euretos knowledge base to power machine learning driven pattern recognition to predict novel gene-disease associations. In combination with the Euretos AI platform, researchers are able to interpret these outcomes in the context of existing knowledge and draw their own conclusions based on the available evidence.
Euretos
Knowledge Base

The world's largest AI-integrated knowledge base

We use AI to recognise and connect relevant information for molecular disease and drug research. Information from hundreds of life sciences databases and millions of publications and patents is harmonised and integrated using machine reading.

The leading AI platform for collaborative disease and drug research

We enable (pre)clinical researchers to take a translational systems biology approach to disease and drug research. Powered by the largest AI integrated knowledge base researchers get access to a suite of applications including Search optimised for disease and drug biology, Analytics for multi-omics & systems biological insights and a Knowledge Graph for exploring biomolecular interaction networks.

- Target Assessment

- Gene-Disease Analysis

- Target Discovery in Oncology

- Target Discovery for Bispecific Antibodies.

- Gene Set Enrichment

- Gene Set Ranking

- Transcription Pathway Analysis.

Search - Optimised for disease and drug biology
Analytics - Systems biological multi-omics insights
Knowledge Graph - Biomolecular interaction analysis
Workflows - Target discovery & assessment (and more)
Enabling world leading pharma, biotech and academic institutions
Logo Johnson & Johnson-1
Logo Grunenthal-2
Logo Daiichi Sankyo-1
PivotSC-logo-RGB-01-1 (1)-1
Logo Sanofi
Logo EMC
Euretos Indication Expansion-2
Customer review

Indication Selection

"“In this project we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities.” "

Global Head Large European Pharma
Euretos Target discovery-2
Customer review

Target Discovery

"“We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI Platform is a mandatory input to our target evaluation meetings”"

Associate Director Target Discovery Large European Biotech
Euretos Biomarker discovery
Customer review

Target Assessment

""We are fascinated by the suggested hypothesis. It was great that even very small expressional changes were captured and a hypothesis was generated. The interpretation was also convincing and consistent. Also the team is well engaged, and had a very good understanding in the background of the project and our research question""

Principal Scientist Large Japanese Pharma

Services

We work closely together with many pharmaceutical & biotech companies, especially in target discovery and indication selection. We enable a data-driven understanding of disease biology by leveraging computational disease models based on AI technologies such as machine reading and learning. We connect data science, translational biology and access to our AI Platform with our customer's disease & drug development expertise to gain collaborative disease insights

Transforming Disease and Drug Research

Get started Free access for academic users!
Book a demo